AUSTRALIAN PRODUCT RECALL

NovoRapid FlexPen

Published 10 February 2022

Product

NovoRapid FlexPen ARTG 133445 (NovoRapid FlexPen insulin aspart (rys) 300U/3mL injection multidose cartridge)

Why it was recalled

The storage instructions inside the product has incorrect labelling. The pack insert incorrectly states: ‘Do not keep the NovoRapid® FlexPen® that you are using, or that you are carrying as a spare, with you.   The storage conditions are correctly stated on the product carton. The correct statement reads: ‘You can carry the NovoRapid® FlexPen® that you are using, or that you are carrying as a spare, with you. You can keep it at room temperature (not above 30°C) or in a refrigerator (2°C - 8°C) for up to 4 weeks.’

Hazard

Storing the product at incorrect temperatures may result in reduced effectiveness, which may increase the risk of adverse health effects.

Read the official notice ↗

Source: Based on ACCC data or other content. ACCC © Commonwealth of Australia. ACCC-owned material is licensed under CC BY 4.0. RecallMatch extracts and formats notice information for screening. Third-party material may have separate rights. Source and reuse terms. Verify details in the official notice. RecallMatch is independent of the ACCC.